Seth Warhaftig brings to HighPoint more than 12 years of experience providing software solutions and services in the life science industry. He possesses a thorough knowledge of the drug development process, specifically in the areas of safety and pharmacovigilance, and clinical development and data management. His experience includes strategic planning, business process optimization, global regulatory compliance, custom system design and development, and system implementation and integration.
Prior to joining HighPoint, Seth was the President and CEO of November Research Group, employed as a Safety and Clinical Solution Specialist for Oracle Corporation, the Executive Director of Worldwide Business Development for NetForce, Inc., and a Senior Consultant for Ernst & Young, LLP. Seth also held the positions of Director of Pharmaceutical and Biotechnology Consulting Services for NetForce, leading a 20 person services group, and Oracle Clinical Development Manager for Oracle Corporation.